123 related articles for article (PubMed ID: 35383519)
1. Pentraxin-3 - a potential biomarker in ANCA-associated vasculitis.
Jonasdottir AD; Antovic A; Qureshi AR; Nordin A; Malmström V; Gunnarsson I; Bruchfeld A
Scand J Rheumatol; 2023 May; 52(3):293-301. PubMed ID: 35383519
[TBL] [Abstract][Full Text] [Related]
2. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
J Mol Med (Berl); 2020 Sep; 98(9):1279-1286. PubMed ID: 32734361
[TBL] [Abstract][Full Text] [Related]
3. IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis.
Padoan R; Gatto M; Ghirardello A; Tonello M; Franco C; Felicetti M; Schiavon F; Doria A
J Autoimmun; 2021 Nov; 124():102725. PubMed ID: 34534841
[TBL] [Abstract][Full Text] [Related]
4. Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.
Simon A; Subra JF; Guilpain P; Jeannin P; Pignon P; Blanchard S; Garo E; Jaillon S; Chevailler A; Renier G; Puéchal X; Bottazzi B; Mantovani A; Delneste Y; Augusto JF
PLoS One; 2016; 11(1):e0147091. PubMed ID: 26797217
[TBL] [Abstract][Full Text] [Related]
5. Measurement of superoxide dismutase: clinical usefulness for patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
Zhang Z; Huang W; Ren F; Luo L; Zhou J; Tang L
Adv Rheumatol; 2023 Jun; 63(1):28. PubMed ID: 37381048
[TBL] [Abstract][Full Text] [Related]
6. The plasma level of mCRP is linked to cardiovascular disease in antineutrophil cytoplasmic antibody-associated vasculitis.
Wu KL; Liang QH; Huang BT; Ding N; Li BW; Hao J
Arthritis Res Ther; 2020 Oct; 22(1):228. PubMed ID: 33008437
[TBL] [Abstract][Full Text] [Related]
7. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
[TBL] [Abstract][Full Text] [Related]
8. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis].
Bulanov NM; Serova AG; Kuznetsova EI; Bulanova ML; Novikov PI; Kozlovskaya LV; Moiseev SV
Ter Arkh; 2017; 89(6):48-55. PubMed ID: 28745689
[TBL] [Abstract][Full Text] [Related]
9. Anti-ETAR and suPAR as markers of disease activity in renal ANCA-associated vasculitis.
Rowaiye OO; Kusztal M; Zabinska M; Bartoszek D; Myszka M; Kościelska-Kasprzak K; Banasik M; Mazanowska O; Klinger M; Krajewska M
Adv Med Sci; 2022 Mar; 67(1):23-28. PubMed ID: 34781174
[TBL] [Abstract][Full Text] [Related]
10. Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study.
Ahn SS; Yoon T; Park YB; Prendecki M; Bhangal G; McAdoo SP; Lee SW
Arthritis Res Ther; 2021 Mar; 23(1):77. PubMed ID: 33685523
[TBL] [Abstract][Full Text] [Related]
11. Correlation between serum cysteine-rich protein 61 and disease activity of antineutrophil cytoplasmic antibody-associated vasculitis.
Yoon T; Ahn SS; Pyo JY; Lee LE; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2021 Sep; 40(9):3703-3710. PubMed ID: 33755835
[TBL] [Abstract][Full Text] [Related]
12. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 36165341
[TBL] [Abstract][Full Text] [Related]
13. Platelet to lymphocyte ratio is associated with the current activity of ANCA-associated vasculitis at diagnosis: a retrospective monocentric study.
Park HJ; Jung SM; Song JJ; Park YB; Lee SW
Rheumatol Int; 2018 Oct; 38(10):1865-1871. PubMed ID: 30088046
[TBL] [Abstract][Full Text] [Related]
14. Association of circulating level of high mobility group box 1 with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis.
Wang C; Gou SJ; Chang DY; Yu F; Zhao MH; Chen M
Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1828-34. PubMed ID: 24591411
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies.
Mosakowska M; Kania DB; Szamotulska K; Rymarz A; Niemczyk S
BMC Nephrol; 2021 Aug; 22(1):290. PubMed ID: 34445984
[TBL] [Abstract][Full Text] [Related]
16. Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis.
Chen M; Wang F; Zhao MH
Rheumatology (Oxford); 2009 Apr; 48(4):355-8. PubMed ID: 19181656
[TBL] [Abstract][Full Text] [Related]
17. Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Ahn SS; Pyo JY; Song JJ; Park YB; Lee SW
Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454396
[No Abstract] [Full Text] [Related]
18. Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis.
Chen SF; Wang FM; Li ZY; Yu F; Zhao MH; Chen M
Arthritis Res Ther; 2015 May; 17(1):129. PubMed ID: 25994214
[TBL] [Abstract][Full Text] [Related]
19. [The expression and clinical significance of neutrophil myeloperoxidase in patients with myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Liu Y; Peng XC; Xu JN; Zheng MJ; Shuai ZW
Zhonghua Nei Ke Za Zhi; 2022 Sep; 61(9):1016-1022. PubMed ID: 36008294
[No Abstract] [Full Text] [Related]
20. Serum Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein-1 Can Predict Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Pilot Monocentric Study.
Ahn SS; Kim JO; Yoon T; Song JJ; Park YB; Lee SW; Park SG
Biomed Res Int; 2019; 2019():7508240. PubMed ID: 31236412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
